Resolution of Ménétrier's disease after eradication of Helicobacter pylori infection;Resolución de la enfermedad de Ménétrier tras la erradicación de la infección por Helicobacter pylori

Gastroenterologia y Hepatologia

Volumn 27, Issue 6, 2004, Pages 357-361

  Santolaria Piedrafita, S ^a   Conde Garcia R ^a   Abascal Agorreta, M ^a   Dominguez Torres I ^a   Ducons Garcia J ^a   Guirao Larranaga R ^a   Montoro Huguet, M ^a  

^a HOSPITAL SAN JORGE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; ERADICATION THERAPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOALBUMINEMIA; MALE; MENETRIER DISEASE; PROTEIN LOSING GASTROENTEROPATHY; STOMACH BIOPSY; STOMACH MUCOSA; TREATMENT OUTCOME;

EID: 3142778650     PISSN: 02105705     EISSN: None     Source Type: Journal    
DOI: 10.1157/13062890     Document Type: Article

References (24)

1. Villardell F. Formas especiales de gastritis. Enfermedad de Ménétrier. En: Villardell F, Rodés J, Malagelada JR, Pajares JM, Pérez Mota A, Moreno González E, et al, editores. Enfermedades digestivas. Madrid: Grupo Aula Médica, 1998; p. 689-97.
2. Bayerdorffer E, Ritter MM, Hatz R, Brooks W, Ruckdeschel G, Stolte M. Healing of protein losing hypertrophic gastropathy by eradication of Helicobacter pylori - is Helicobacter pylori a pathogenic factor in Ménétrier's disease? Gut 1994;35:701-14.
3. Kawasaki M, Hizawa K, Aoyagi K, Nakamura S, Fujishima M. Ménétrier's disease associated with Helicobacter pylori infection: resolution of enlarged gastric folds and hypoproteinemia after antibacterial treatment. Am J Gastroenterol 1997;92:1909-12.
4. Badov D, Lambert JR, Finlay M, Balazs ND. Helicobacter pylori as a pathogenic factor in Ménétrier's disease. Am J Gastroenterol 1998;93:1976-9.
5. Shimoyama T, Fukuda S, Tanaka M, Mikami T, Yamagata R, Yoshimura T, et al. Healing of cimetidine-resistant Menetrier's disease by erradication of Helicobacter pylori infection. J Clin Gastroenterol 1998;27:349-50.
6. Kaneko T, Akamatsu T, Gotoh A, Shimodaira K, Shimizu T, Kiyosawa K, et al. Remission of Ménétrier's disease after a prolonged period with therapeutic eradication of Helicobacter pylori. Am J Gastroenterol 1999;94:272-3.
7. Raderer M, Oberhuber G, Templ E, Wagner L, Pötzi R, Wrba F, et al. Successful symptomatic management of a patient with Ménétrier's disease with long-term antibiotic treatment. Digestion 1999;60:358-62.
8. Madsen LG, Taskiran M, Madsen JL, Bytzer P. Ménétrier's disease and Helicobacter pylori: normalization of gastrointestinal protein loss after eradication therapy. Dig Dis Sci 1999;44: 2307-12.
9. Di Vita G, Patti R, Aragona F, Leo P, Montalto G. Resolution of Ménétrier's disease after Helicobacter pylori eradicating therapy. Dig Dis 2001;19:179-83.
10. Dempsey PJ, Goldenring JR, Soroka CJ, Modlin IM, McClure RW, Lind CD, et al. Possible role of transforming growth factor alpha in the pathogenesis of Ménétrier's disease: supportive evidence form humans and transgenic mice. Gastroenterology 1992;103:1950-63.
11. Sferra TJ, Pawel BR, Qualman SJ, Li BU. Ménétrier disease of childhood: role of cytomegalovirus and transforming growth factor alpha. J Pediatr 1996;128:213-9.
12. Stolte M, Batz C, Eidt S. Giant fold gastritis-a special form of Helicobacter pylori associated gastritis. Z Gastroenterol 1993; 31:289-93.
13. Wolfsen HC, Carpenter HA, Talley NJ. Ménétrier's disease: a form of hypertrophic gastropathy or gastritis? Gastroenterology 1993;104:1310-9.
14. Groisman GM, George J, Berman D, Harpaz N. Resolution of protein-losing hypertrophic lymphocytic gastritis with therapeutic eradication of Helicobacter pylori. Am J Gastroenterol 1994;89:1548-51.
15. Meuwissen SG, Ridwan BU, Hasper HJ, Innemee G. Hypertrophic protein-losing gastropathy. A retrospective analysis of 40 cases in The Netherlands. The Dutch Ménétrier Study Group. Scand J Gastroenterol 1992;194(Suppl):1-7.
16. Fieber SS, Rickert RR. Hyperplastic gastropathy. Analysis of 50 selected cases from 1955-1980. Am J Gastroenterol 1981; 76:321-9.
17. Kelly DG, Miller LJ, Malagelada JR, Huizenga KA, Markowitz H. Giant hypertrophic gastropathy (Ménétrier's disease): pharmacologic effects on protein leakage and mucosal ultrastructure. Gastroenterology 1982;83:581-9.
18. Searcy RM, Malagelada JR. Ménétrier's disease and idiopathic hypertrophic gastropathy. Ann Intern Med 1984;100:565-70.
19. Komorowski RA, Caya JG, Geenen JE. The morphologic spectrum of large gastric folds: utility of the snare biopsy. Gastrointest Endosc 1986;32:190-2.
20. Calvet X, Sanfeliu I, Musulen E, Mas P, Dalmau B, Gil M, et al. Evaluation of Helicobacter pylori diagnostic methods in patients with liver cirrhosis. Aliment Pharmacol Ther 2002;16: 1283-9.
21. Vilella A, Ginés A, Dolz C. Linfoma gástrico tipo MALT. Med Clin (Barc) 2003;120:349-52.
22. Stolte M, Batz CH, Bayerdorffer E, Eidt S. Helicobacter pylori eradication in the treatment and differential diagnosis of giant folds in the corpus and fundus of the stomach. Z Gastroenterol 1995;33:198-201.
23. Yeaton P, Frierson HF Jr. Octreotide reduces enteral protein losses in Ménétrier's disease. Am J Gastroenterol 1993;88: 95-8.
24. Burdick JS, Chung E, Tanner G, Sun M, Paciga JE, Cheng JQ, et al. Treatment of Ménétrier's disease with a monoclonal antibody against the epidermal growth factor receptor. N Engl J Med 2000;343:1697-701.